Trial intelligence / Profile preview

Pulmicort Nasal Packing in Chronic Sinusitis

NCT01197612Phase 3Completed

Sponsor
University of Michigan
Start
Sep 2010
Primary completion
Jun 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, open-label trial of budesonide in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by University of Michigan. Primary endpoint: Olfaction at 3 weeks. Started Sep 2010; status: completed.

02

Drugs

budesonide
03

Conditions

chronic rhinosinusitis with nasal polyps (CRSwNP)

Beyond the preview

Go deeper on NCT01197612.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01197612.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call